about
Treatment options for myelodysplastic syndromes.Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring SystemSurvival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience.Azacitidine.Myelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"?Emerging drugs for the treatment of myelodysplastic syndrome.Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalitiesPhase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes.Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years.Valuation of transfusion-free living in MDS: results of health utility interviews with patients.Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment.High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study.
P2860
Q33364350-51EF2729-D011-4BA0-B921-C214912E5FD1Q33380307-DCB5FD4F-23B4-4473-ADBC-A2F918F77EC7Q34187884-A569DB70-5B0A-4F82-A468-0B141E685850Q34414813-E1C6BD67-F008-4EB8-AA78-E27A1910874BQ35001132-34FD60A6-29CE-430A-8216-C078B89D38BFQ36219655-2A5728DF-0923-4528-90B3-8781A14012E1Q36941047-668F9B46-3AA1-437C-8BEA-CC39AC4C6206Q37125405-BB20EFC1-062E-4FF6-B35D-FBF381AE84D6Q37271941-3FF13F65-8051-4266-A447-3EC1D71AF648Q37351945-A4822356-8B83-42B9-9C3F-A1D670C2EEA8Q45786458-E6DC0465-E215-4EA6-81F6-FADA8195C72BQ50735246-2E584694-3E4A-48E4-9908-16EA1CE2E81F
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Novel therapies for myelodysplastic syndromes.
@ast
Novel therapies for myelodysplastic syndromes.
@en
type
label
Novel therapies for myelodysplastic syndromes.
@ast
Novel therapies for myelodysplastic syndromes.
@en
prefLabel
Novel therapies for myelodysplastic syndromes.
@ast
Novel therapies for myelodysplastic syndromes.
@en
P356
P1433
P1476
Novel therapies for myelodysplastic syndromes.
@en
P2860
P304
P356
10.1002/CNCR.20381
P407
P577
2004-07-01T00:00:00Z